Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gabelli Mathers Fund
Rye, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The Gabelli Mathers Fund is an open-end mutual fund managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors. Originally established as the Mathers Fund in 1965, it was acquired by the Gabelli organization in 1999 and is recognized for its historically defensive investment posture. The fund's primary investment objective is capital appreciation, which it pursues by investing in common stocks while frequently employing hedging strategies, such as short selling and maintaining significant cash positions, to mitigate market volatility. It is a financial investment vehicle rather than a biotechnology or life sciences research company.
- Industry
- Investors
Beyond the preview
Go deeper on Gabelli Mathers Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gabelli Mathers Fund.